13F Pro

SEC Form 4 reporting owner

Audhya Paul K.

Audhya Paul K. has filed 23 Form 4 transactions reported between November 21, 2025 and June 11, 2026, as CHIEF MEDICAL OFFICER of KalVista Pharmaceuticals, Inc..

Name as filed: Audhya Paul K.

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$386K
7 lines
Companies
1
with Form 4 filings
Latest transaction
Jun 11, 2026
transaction date

Roles and reported holdings

  • KALVKalVista Pharmaceuticals, Inc.
    Nov 21, 2025 – Jun 11, 2026

    CHIEF MEDICAL OFFICER

    Held directly150,260 sh as of May 26, 2026 · Form 4

    24 months: $386K sold

Transaction history

All 23 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Jun 11, 2026KALVCHIEF MEDICAL OFFICERDisposition to issuerCode D · direct93,750—Form 4
Jun 11, 2026KALVCHIEF MEDICAL OFFICERDisposition to issuerCode D · direct68,750—Form 4
Jun 11, 2026KALVCHIEF MEDICAL OFFICERDisposition to issuerCode D · direct40,000—Form 4
Jun 11, 2026KALVCHIEF MEDICAL OFFICERDisposition to issuerCode D · direct25,800—Form 4
Jun 11, 2026KALVCHIEF MEDICAL OFFICERDisposition to issuerCode D · direct100,000—Form 4
Jun 11, 2026KALVCHIEF MEDICAL OFFICERDisposition to issuerCode D · direct150,260—Form 4
May 26, 2026KALVCHIEF MEDICAL OFFICEROpen-market saleCode S · direct2,239$60K@ $26.78Form 4
May 22, 2026KALVCHIEF MEDICAL OFFICEROption exerciseCode M · direct5,000—Form 4
May 22, 2026KALVCHIEF MEDICAL OFFICEROpen-market saleCode S · direct2,685$72K@ $26.78Form 4
May 21, 2026KALVCHIEF MEDICAL OFFICEROption exerciseCode M · direct6,250—Form 4
May 18, 2026KALVCHIEF MEDICAL OFFICEROpen-market saleCode S · direct1,032$28K@ $26.76Form 4
May 17, 2026KALVCHIEF MEDICAL OFFICEROption exerciseCode M · direct2,419—Form 4
Apr 17, 2026KALVCHIEF MEDICAL OFFICEROpen-market saleCode S · direct2,686$54K@ $20.22Form 4
Apr 16, 2026KALVCHIEF MEDICAL OFFICEROption exerciseCode M · direct6,250—Form 4
Feb 23, 2026KALVCHIEF MEDICAL OFFICEROpen-market saleCode S · direct5,354$83K@ $15.57Form 4
Feb 22, 2026KALVCHIEF MEDICAL OFFICEROption exerciseCode M · direct5,000—Form 4
Feb 21, 2026KALVCHIEF MEDICAL OFFICEROption exerciseCode M · direct6,250—Form 4
Feb 18, 2026KALVCHIEF MEDICAL OFFICEROpen-market saleCode S · direct1,163$17K@ $15.00Form 4
Feb 17, 2026KALVCHIEF MEDICAL OFFICEROption exerciseCode M · direct2,419—Form 4
Jan 16, 2026KALVCHIEF MEDICAL OFFICERGrant or awardCode A · direct100,000—Form 4
Nov 24, 2025KALVCHIEF MEDICAL OFFICEROpen-market saleCode S · direct5,296$71K@ $13.45Form 4
Nov 22, 2025KALVCHIEF MEDICAL OFFICEROption exerciseCode M · direct5,000—Form 4
Nov 21, 2025KALVCHIEF MEDICAL OFFICEROption exerciseCode M · direct6,250—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.